Association between New 340B Program Participation and Commercial Insurance Spending on Outpatient Biologic Oncology Drugs

Jessica Chang, Pinar Karaca-Mandic, Sayeh Nikpay, Molly Moore Jeffery

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Association between New 340B Program Participation and Commercial Insurance Spending on Outpatient Biologic Oncology Drugs'. Together they form a unique fingerprint.

Medicine & Life Sciences

Social Sciences